Learning objectives

After watching this webinar, participants will understand

• NOAC management after event; practical advice about stopping, reducing, or switching a dose;
• post-NOAC treatment – adherence and dosing regimen;
• primary and secondary prevention of strokes and bleeding;
• right molecule in right dose to right patient in right time approach;
• what the ESC Guidelines say;
• efficacy and safety of anticoagulation therapy (VKA, NOAC, factor XI inhibitors);
• finding a balance between stroke and bleeding in elderly patients;
• balancing between major bleeding such as ICH and GI bleeding; and 
• the focus on long-lasting RWE studies, such as ETNA-AF’s four-year follow-up.

Needs assessment and expected educational outcome

To understand optimal treatment options including indications for oral anticoagulation for patients after cerebrovascular events.

Main topic

• Clinical Skills, Other

Related topics

• Treatment
• Pathophysiology and Mechanisms 
• Stroke in Atrial Fibrillation 
• Oral Anticoagulation 
• Stroke Prevention 

This webinar is designed for electrophysiologists specialists but also cardiologists wishing to update their scientific knowledge on the topic. 

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).